Kala Bio, Inc. · NASDAQ:KALA
David E. Lazar reported a 5.18% stake in Kala Bio, Inc. (Schedule 13D)
Event Jan 30, 2026 · Filed Feb 6, 2026
David E. Lazar reported a 5.18% stake in Kala Bio, Inc., 49,500,000 shares, with active intent on Jan 30, 2026. Filed Feb 6, 2026 (Schedule 13D).
- Stake
- 5.18%
- Shares
- 49,500,000
- Intent
- Active
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| David E. Lazar | 5.18% | 49,500,000 |
Source
Related
- Kala Bio, Inc.
- Lazar David E.
- Kala Bio, Inc. shareholders
- Schedule 13D/A · Lazar David E. · Jul 2, 2026
- Schedule 13G · Labkowski Nachum · Oct 19, 2026
- Schedule 13G/A · Baker Bros. Advisors LP · May 15, 2026
- Schedule 13G/A · Baker Bros. Advisors LP · Feb 17, 2026
- Schedule 13G · LifeSci Capital LLC · Jan 13, 2026
- Schedule 13G · Oxford Finance LLC · Dec 3, 2025